CEO and Managing Director, Tim Oldham participates in Resource Connect Asia’s 12 September 2025 Technology Webinar. Dr Oldham discusses the pillars powering AdAlta’s "East to West" cellular immunotherapy strategy:

• The China innovation boom that is disrupting the global biotech ecosystem;

• The extraordinary power of reprogrammed human immune cells as living drugs to fight cancer;

• The steps AdAlta is taking to bring these incredible innovations to global patients using Australian expertise and the opportunities that creates for Adlta shareholders.

The presentation and questions are in English with Mandarin Chinese subtitles and can be viewed here: https://www.resourceconnectasia.com/asianwebinar1209

Dr Oldham also participates in a panel with Charles River Laboratories and Dark Horse Consulting to discus "Shaping the Future of Cell and Gene Therapy: A Holistic Approach to Manufacturing, Quality, and Regulatory Compliance" on 3 September.

Registration details in the ASX announcement.